Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
This product will be manufactured at Lupin’s Pithampur facility in India
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
The academy has secured partnerships with 15 esteemed hospitals
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Subscribe To Our Newsletter & Stay Updated
